FilingSEC EDGAR8-K
CytoSorbents Regains Compliance with Nasdaq Minimum Bid Price Requirement and Continues Addressing Market Value Requirement
· SEC accepted
StageCompliance Regained
Filing content
The company received notification of regained compliance with the minimum bid price requirement and is working to address the market value requirement by December 28, 2026.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…